SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19672597
Source:
http://linkedlifedata.com/resource/pubmed/id/19672597
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0020433
,
umls-concept:C0030705
,
umls-concept:C0537026
,
umls-concept:C1514756
,
umls-concept:C1516119
,
umls-concept:C1882417
pubmed:issue
1
pubmed:dateCreated
2009-9-17
pubmed:abstractText
To report a single case of uridine glucuronosyltransferase 1A1 (UGT1A1) polymorphism and hyperbilirubinemia in a patient who received sorafenib.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Benzenesulfonates
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Glucuronosyltransferase
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines
,
http://linkedlifedata.com/resource/pubmed/chemical/bilirubin...
,
http://linkedlifedata.com/resource/pubmed/chemical/sorafenib
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1432-0843
pubmed:author
pubmed-author:ChristensenOlafO
,
pubmed-author:ChuQuincy S-CQS
,
pubmed-author:DasSomaS
,
pubmed-author:Meza-JuncoJudithJ
,
pubmed-author:RajagopalanPrabhuP
,
pubmed-author:SawyerMichael BMB
,
pubmed-author:StefanyschynRuslanR
pubmed:issnType
Electronic
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-4
pubmed:meshHeading
pubmed-meshheading:19672597-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:19672597-Benzenesulfonates
,
pubmed-meshheading:19672597-Carcinoma, Hepatocellular
,
pubmed-meshheading:19672597-Clinical Trials, Phase I as Topic
,
pubmed-meshheading:19672597-Cyclophosphamide
,
pubmed-meshheading:19672597-Doxorubicin
,
pubmed-meshheading:19672597-Glucuronosyltransferase
,
pubmed-meshheading:19672597-Humans
,
pubmed-meshheading:19672597-Hyperbilirubinemia
,
pubmed-meshheading:19672597-Liver Cirrhosis
,
pubmed-meshheading:19672597-Liver Neoplasms
,
pubmed-meshheading:19672597-Male
,
pubmed-meshheading:19672597-Middle Aged
,
pubmed-meshheading:19672597-Polymorphism, Genetic
,
pubmed-meshheading:19672597-Pyridines
pubmed:year
2009
pubmed:articleTitle
UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.
pubmed:affiliation
Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada. judimeza@cancerboard.ab.ca
pubmed:publicationType
Journal Article
,
Case Reports